Innovation Pharmaceuticals Inc. (IPIX)
OTCMKTS: IPIX · Delayed Price · USD
0.0003
0.00 (0.00%)
Aug 30, 2024, 4:00 PM EDT - Market closed
IPIX Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Revenue | - | - | 0.02 | - | 0.42 | - | Upgrade
|
| Gross Profit | - | - | 0.02 | - | 0.42 | - | Upgrade
|
| Selling, General & Admin | 1.49 | 1.48 | 1.96 | 2 | 2.27 | 1.95 | Upgrade
|
| Research & Development | 0.87 | 1.46 | 4.81 | 7.02 | 2.79 | 4.34 | Upgrade
|
| Operating Expenses | 2.36 | 2.94 | 6.78 | 9.02 | 5.06 | 6.3 | Upgrade
|
| Operating Income | -2.36 | -2.94 | -6.76 | -9.02 | -4.64 | -6.3 | Upgrade
|
| Interest Expense | -0.06 | -0.06 | -0.12 | -4.86 | -0.26 | -2.2 | Upgrade
|
| Earnings From Equity Investments | -0.21 | -0.17 | -0.02 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | -0.18 | - | 0.1 | 0.36 | Upgrade
|
| EBT Excluding Unusual Items | -2.62 | -3.17 | -7.07 | -13.87 | -4.79 | -8.14 | Upgrade
|
| Asset Writedown | - | - | -0.14 | - | -0.64 | -0.15 | Upgrade
|
| Other Unusual Items | - | - | 0.17 | - | -1.21 | -0.39 | Upgrade
|
| Pretax Income | -2.62 | -3.17 | -7.04 | -13.87 | -6.65 | -8.68 | Upgrade
|
| Net Income | -2.62 | -3.17 | -7.04 | -13.87 | -6.65 | -8.68 | Upgrade
|
| Net Income to Common | -2.62 | -3.17 | -7.04 | -13.87 | -6.65 | -8.68 | Upgrade
|
| Shares Outstanding (Basic) | 509 | 506 | 504 | 386 | 238 | 178 | Upgrade
|
| Shares Outstanding (Diluted) | 509 | 506 | 504 | 386 | 238 | 178 | Upgrade
|
| Shares Change (YoY) | -1.41% | 0.38% | 30.48% | 61.96% | 33.78% | 23.33% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.04 | -0.03 | -0.05 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.04 | -0.03 | -0.05 | Upgrade
|
| Free Cash Flow | -1.99 | -2.11 | -6.28 | -9.5 | -4.16 | -6.33 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.02 | -0.02 | -0.04 | Upgrade
|
| Gross Margin | - | - | 100.00% | - | 100.00% | - | Upgrade
|
| Operating Margin | - | - | -37544.44% | - | -1095.74% | - | Upgrade
|
| Profit Margin | - | - | -39116.67% | - | -1571.63% | - | Upgrade
|
| Free Cash Flow Margin | - | - | -34888.89% | - | -982.51% | - | Upgrade
|
| EBITDA | -1.99 | -2.57 | -6.38 | -8.64 | -4.26 | -5.93 | Upgrade
|
| D&A For EBITDA | 0.37 | 0.37 | 0.38 | 0.38 | 0.37 | 0.37 | Upgrade
|
| EBIT | -2.36 | -2.94 | -6.76 | -9.02 | -4.64 | -6.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.